Impirica Inc.

At Impirica we combine cutting-edge technology with proven research to deliver driver assessment tools for commercial fleets, governments, insurers, and the medical community. We provide service, software and hardware solutions that help identify if medications or medical conditions have affected a person’s ability to drive. Impirica, formerly DriveABLE, has been providing driver risk assessments for over 15 years with over 90,000 assessments performed to date. Impirica products are licensed and distributed across North America, New Zealand and South Korea. It is our goal to protect competent drivers, accurately identify cognitively unsafe drivers, and to help improve safety on our roads. OUR MISSION Creating safer communities through the fusion of science and technologies. HISTORY At the request of physicians, Dr. Allen Dobbs and his team at the Neurocognitive Research Unit of the Northern Alberta Regional Geriatric Program, were asked to find a test which could assess patients who were still driving and had a cognitively impairing medical condition. After an exhaustive literature review, no such assessment test was found. The physician group then tasked Dr. Dobb’s team with developing an evidence-based test that was specific to driving and cognitive impairment. Eight years and over 1500 subjects later, the team had developed both an In-Office and On-Road test which, together, formed the only assessment system worldwide that assessed a driver based on the level of cognitive impairment caused by their medical condition. DriveABLE was established because of a large, and growing need in the community for fair, evidence-based assessments of medically at-risk drivers with generalized cognitive impairment. Impirica strives to build on the legacy of that science and continue to develop cause-agnostic, risk-assessment tools that make our communities and workplaces safer.